These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9812917)
1. Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system. Bouchie JL; Hansen H; Feener EP Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1771-9. PubMed ID: 9812917 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology. Brown C; Pan X; Hassid A Circ Res; 1999 Apr; 84(6):655-67. PubMed ID: 10189353 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020 [TBL] [Abstract][Full Text] [Related]
4. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle. Hamad AM; Range S; Holland E; Knox AJ Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856 [TBL] [Abstract][Full Text] [Related]
5. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948 [TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells. Yoshizumi M; Tsuji H; Nishimura H; Masuda H; Kunieda Y; Kawano H; Kimura S; Sugano T; Kitamura H; Nakagawa K; Nakagawa M Thromb Haemost; 1999 Nov; 82(5):1497-503. PubMed ID: 10595644 [TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism. Suenobu N; Shichiri M; Iwashina M; Marumo F; Hirata Y Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):140-6. PubMed ID: 9888876 [TBL] [Abstract][Full Text] [Related]
12. Requirement of protein tyrosine phosphatase SHP2 for NO-stimulated vascular smooth muscle cell motility. Brown C; Lin Y; Hassid A Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1598-605. PubMed ID: 11557549 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide attenuates the expression of natriuretic peptide receptor C and associated adenylyl cyclase signaling in aortic vascular smooth muscle cells: role of MAPK. Arejian M; Li Y; Anand-Srivastava MB Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1859-67. PubMed ID: 19252090 [TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide provokes a dramatic increase in cyclic GMP formation and markedly inhibits muscarinic-stimulated Ca2+ mobilisation in SV-40 transformed cat iris sphincter smooth muscle (SV-CISM-2) cells. Ding KH; Ali N; Abdel-Latif AA Cell Signal; 1999 Feb; 11(2):87-94. PubMed ID: 10048785 [TBL] [Abstract][Full Text] [Related]
15. Dual cell cycle-specific mechanisms mediate the antimitogenic effects of nitric oxide in vascular smooth muscle cells. Sarkar R; Gordon D; Stanley JC; Webb RC J Hypertens; 1997 Mar; 15(3):275-83. PubMed ID: 9468455 [TBL] [Abstract][Full Text] [Related]
16. Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing big conductance calcium-activated potassium channels of vascular smooth muscle. Liang CF; Au AL; Leung SW; Ng KF; Félétou M; Kwan YW; Man RY; Vanhoutte PM J Pharmacol Exp Ther; 2010 Jul; 334(1):223-31. PubMed ID: 20332186 [TBL] [Abstract][Full Text] [Related]